Cleared Traditional

K142261 - Ultraverse 035 PTA Balloon Dilatation C...

K142261 is the FDA 510(k) clearance for Ultraverse 035 PTA Balloon Dilatation C... by Bard Peripheral Vascular, Inc.. It is a Class 2 Cardiovascular device (product code LIT) cleared through the Traditional 510(k) pathway after a 41-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 2014
Decision
41d
Days
Class 2
Risk

K142261 is an FDA 510(k) clearance for the Ultraverse 035 PTA Balloon Dilatation Catheter. Classified as Catheter, Angioplasty, Peripheral, Transluminal (product code LIT), Class II - Special Controls.

Submitted by Bard Peripheral Vascular, Inc. (Tempe, US). The FDA issued a Cleared decision on September 24, 2014 after a review of 41 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1250 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Bard Peripheral Vascular, Inc. devices

Submission Details

510(k) Number K142261 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 14, 2014
Decision Date September 24, 2014
Days to Decision 41 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review Yes - reviewed by an FDA-accredited third party
Regulatory Context
Review time vs. panel average
84d faster than avg
Panel avg: 125d · This submission: 41d
Pathway characteristics
Predicate-based equivalence. No clinical trials required. Third-party reviewed.

Device Classification

Product Code LIT Catheter, Angioplasty, Peripheral, Transluminal
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1250
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - LIT Catheter, Angioplasty, Peripheral, Transluminal

All 194
Devices cleared under the same product code (LIT) and FDA review panel - the closest regulatory comparables to K142261.
Passeo-35 PTA Catheter
K142379 · Biotronik, Inc. · Dec 2014
Fortrex 0.035 OTW PTA Balloon Catheter
K142654 · Covidien, LLC · Oct 2014
PTA BALLOON DILATATION CATHETER
K141150 · Boston Scientific Corp · Sep 2014
MUSTANG BALLOON DILATATION CATHETER/CHARGER PTA BALLOON DILATATION CATHETER
K141521 · Boston Scientific Corporation · Aug 2014
GLADIATOR ELITE PTA BALLOON DILATATION CATHETER
K132810 · Boston Scientific Corp · Feb 2014
ADVANCE 34LP LOW PROFILE PTA BALLOON DILATATION CATHETER
K132020 · Cook, Inc. · Oct 2013